A recent study evaluates the potential of Nanosota-EB1 and Nanosota-EB2, nanobody inhibitors targeting the Ebola virus.

Introducing the M@P nanoplatform: a novel approach to cancer therapy that triggers pyroptosis and ferroptosis, boosting ...